Gainesville, Fla. - One medication approved for gum disease appears to be effective against moderate facial acne at sub-antimicrobial doses given over six months.
The Weekly Roundup: September 18-22
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Colloidal Oatmeal Effective in Improving Atopic Dermatitis in Black Children
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Frontline Forum Part 4: Improving Basal Cell Carcinoma Management
Native American and Indigenous Communities Face Dermatologic Barriers to Care, Disparities, and More